NCT03263910View on ClinicalTrials.gov

Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

August 10, 2018

Study Completion Date

August 17, 2018

Conditions
Patients Undergoing Gastrointestinal Endoscopy
Interventions
DRUG

NPO-11

20 ml NPO-11

DRUG

Placebo

20 ml NPO-11(Placebo)

Trial Locations (4)

Unknown

East China, East China

North China

Northwest China

South China

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY